FEATURED TRIALS

IgA Nephropathy
Researching the safe and effective treatment of BHV-1400 for patients with IgA Nephropathy (IgAN)
Drug: BHVN-1400
Age: 18-65
Phase: 1

Graves' disease
We're conducting a study to see if BHV-1300 is a safe treatment for people with Graves' disease.
Drug: BHV-1300
Age: 18-65
Phase: 1

Parkinson's Disease
Researching an investigational treatment to change the course of Parkinson's disease.
Drug: BHV-8000
Age: 40-85
Phase: 2/3

Generalized Epilepsy
Researching an Investigational Treatment Option for Idiopathic Generalized Epilepsy
Drug: BHV-7000
Age: 18-75
Phase: 3

FOCAL EPILEPSY
Researching an investigational treatment option for Focal Onset Epilepsy
Drug: BHV-7000
Age: 18-75
Phase: 2/3